These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2910508)

  • 21. Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents.
    Rathore P; Yaseen S; Ovais S; Bashir R; Yaseen R; Hameed AD; Samim M; Gupta R; Hussain F; Javed K
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1685-91. PubMed ID: 24630557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C; Alam MS; Hamid H; Javed K; Shafi S; Ali Y; Alam P; Pasha MA; Dhulap A; Bano S; Nazreen S; Haider S
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5298-303. PubMed ID: 25442322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model for assessing interference.
    Kroll MH; Ruddel M; Blank DW; Elin RJ
    Clin Chem; 1987 Jul; 33(7):1121-3. PubMed ID: 3594838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit.
    Wu C; Wang M; Tang Q; Luo R; Chen L; Zheng P; Zhu W
    Molecules; 2015 Oct; 20(10):19361-71. PubMed ID: 26512636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JNK-mediated transcriptional upregulation of RhoB is critical for apoptosis of HCT-116 colon cancer cells by a novel diarylsulfonylurea derivative.
    Kim DM; Won M; Chung CS; Kim S; Yim HJ; Jung SH; Jeong S
    Apoptosis; 2010 Dec; 15(12):1540-8. PubMed ID: 20683666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug action.
    Sosinski J; Thakar JH; Germain GS; Harwood FC; Houghton PJ
    Biochem Pharmacol; 1993 May; 45(10):2135-42. PubMed ID: 8512595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antitumor activity of N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea, LY 186641 against various human cancers using subrenal capsule assay].
    Inoue K; Wang Y; Shibata H; Mukaiyama T; Hamada K; Ogawa M
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):85-8. PubMed ID: 2297241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of enterotoxin-induced porcine colonic secretion by diarylsulfonylureas in vitro.
    O'Donnell EK; Sedlacek RL; Singh AK; Schultz BD
    Am J Physiol Gastrointest Liver Physiol; 2000 Nov; 279(5):G1104-12. PubMed ID: 11053008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum ultrafiltration for the elimination of endogenous interfering substances in creatinine determination.
    da Fonseca-Wollheim F; Heinze KG; Lomsky K; Schreiner H
    J Clin Chem Clin Biochem; 1988 Aug; 26(8):523-5. PubMed ID: 3221182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells.
    Alonso MM; Encío I; Martínez-Merino V; Gil M; Migliaccio M
    Br J Cancer; 2001 Nov; 85(9):1400-2. PubMed ID: 11720481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.
    Kwon YE; Park JY; Kim WK
    Anticancer Res; 2007; 27(1A):321-6. PubMed ID: 17352249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) at an external site.
    Morré DJ
    Biochim Biophys Acta; 1995 Dec; 1240(2):201-8. PubMed ID: 8541291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.
    Morré DJ; Wilkinson FE; Kim C; Cho N; Lawrence J; Morré DM; McClure D
    Biochim Biophys Acta; 1996 Apr; 1280(2):197-206. PubMed ID: 8639694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
    Rostom SA
    Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.
    Morré DJ; Wu LY; Morré DM
    Biochim Biophys Acta; 1995 Nov; 1240(1):11-7. PubMed ID: 7495842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.
    Neubauer BL; Merriman RL; Best KL; Goode RL; Sarosdy MF; Tanzer LR; Howbert JJ
    J Urol; 1992 Feb; 147(2):500-4. PubMed ID: 1732631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
    Forouzesh B; Takimoto CH; Goetz A; Diab S; Hammond LA; Smetzer L; Schwartz G; Gazak R; Callaghan JT; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2003 Nov; 9(15):5540-9. PubMed ID: 14654534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984).
    Morré DJ; Jacobs E; Sweeting M; de Cabo R; Morré DM
    Biochim Biophys Acta; 1997 Apr; 1325(1):117-25. PubMed ID: 9106489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the intracellular distribution and binding in human adenocarcinoma cells of N-(4-azidophenylsulfonyl)-N'-(4-chlorophenyl)urea (LY219703), a photoaffinity analogue of the antitumor diarylsulfonylurea sulofenur.
    Houghton PJ; Sosinski J; Thakar JH; Boder GB; Grindey GB
    Biochem Pharmacol; 1995 Mar; 49(5):661-8. PubMed ID: 7887981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer.
    Taylor CW; Alberts DS; Peng YM; McCloskey TM; Matzner M; Roe DJ; Plezia PM; Grindey GB; Hamilton M; Seitz D
    J Natl Cancer Inst; 1992 Dec; 84(23):1798-802. PubMed ID: 1433369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.